ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 711830 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 711830; 2) Community: the network communities that were significantly associated with the response to NSC 711830; 3) Molecule: the relationships between components within communities and NSC 711830; 4) MDR: the compounds that were significantly associated with the NSC 711830.

NSC Compound Enrichment Correlation
NSC 716002 Null 0.0135714101922724 0.44025823
NSC 718781 Erlotinib hydrochloride 0.0135714101922724 -0.26679883
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0135714101922724 0.36039935
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0135714101922724 0.36210397
NSC 753427 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.0135714101922724 0.17665356
NSC 762346 Null 0.0135714101922724 0.21033111
NSC 114346 Null 0.0139796580235792 0.55971008
NSC 129757 Null 0.0139796580235792 0.14085892
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0139796580235792 0.43405781
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0139796580235792 0.20710047
Total:90  Current:34    [First] [Prev] [Next] [Last]